Verano Hldgs Corp (OP:VRNOF)

1.260 UNCHANGED

Last Price Updated: 3:59 PM EST, Nov 3, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Verano Hldgs Corp

< Previous 1 2 3 4 5 6 7 8 9

...

23 24 Next >

Largest Cannabis MSO Stocks Down 9% In February; Still Up 26% YTD ↗

March 01, 2024

Only two of the 7 stocks in the American Cannabis MSO Stocks Index were up in February with the index going down 8.9% but remaining up 25.9% YTD.

Via Talk Markets

Topics Cannabis

Pot Stock Verano CEO Says 'The Sky Is The Limit' For Its 2024 Achievements Despite Higher Net Loss QoQ ↗

February 29, 2024

Via Benzinga

Topics Cannabis

3 Cannabis Stocks Blazing a Trail to Legalization ↗

February 27, 2024

Capitalizing on the regulatory momentum, wager on these top cannabis stocks primed for robust expansion in the evolving market.

Via InvestorPlace

Topics Cannabis

Here's Where To Buy Legal Weed: Seven States Open New Cannabis Dispensaries ↗

February 26, 2024

The cannabis revolution continues to grow with new dispensary openings across seven states. In Texas, Right on Brands and Texas Original launched new retail locations, while New York welcomed RIV...

Via Benzinga

Topics Cannabis

7 Largest Cannabis MSO Stocks Jumped 8% This Week ↗

February 24, 2024

The 7 stocks in the American Cannabis MSO Stocks Index are up 8%, on average, this week and are now up 41.7% YTD. Here's the latest.

Via Talk Markets

Topics Cannabis

Overweight Rating Highlights Jushi Holdings' Market Edge: Weed Stock Valuation Gap Analysis ↗

February 21, 2024

Zuanic & Associates gave Jushi Holdings Inc. (CSE: JUSH) (OTC: JUSHF) an Overweight rating as the firm begins its coverage of the marijuana company.

Via Benzinga

The 3 Best Cannabis Stocks to Buy in February 2024 ↗

February 18, 2024

There's a lot of highs and lows in the marijuana industry, but these are the three best cannabis stocks to buy for significant returns.

Via InvestorPlace

Topics Cannabis

As Expected, Cannabis MSOs Continue To Decline ↗

February 17, 2024

Last week I suggested that if the performance of the American Cannabis MSO Stocks Index (-7.1%) was any indication, then the hype in cannabis MSOs was over. That is indeed the case, as reflected by the...

Via Talk Markets

Topics Cannabis

Study Says Cannabis Doesn’t Up Vehicle Accident Risk But Alcohol Intake Does

February 14, 2024

Via CannabisNewsWire

Topics Cannabis

Fast Track Recap: Colorado & Michigan Weed Sales Decline, Virginia Eyes Legal Market, Stock Winners & Losers ↗

February 12, 2024

Colorado's cannabis market, once a frontrunner in the U.S. for recreational marijuana sales, has experienced a downturn.

Via Benzinga

Topics Cannabis

As Expected, Cannabis MSOs Starting To Decline - Again ↗

February 10, 2024

As a caveat to last week's article I said the hype in cannabis MSOs would likely end soon, and that's what happened this week.

Via Talk Markets

Topics Cannabis

Touchdown In Las Vegas: Exploring Nevada's Cannabis Field, Market And Companies Ahead Of Super Bowl LVIII ↗

February 09, 2024

As Super Bowl LVIII readies to get underway at Allegiant Stadium in Las Vegas this Sunday, Nevada's cannabis industry, underpinned by recent legislative reforms and strategic positioning, is set to...

Via Benzinga

Topics Cannabis

Illinois Weed Scorecard, Super Bowl Edition: Market Leaders, Store Surge And Sales Analysis ↗

February 09, 2024

Illinois' booming cannabis market is under the microscope in Pablo Zuanic's latest report from Zuanic & Associates. With dispensary numbers on the rise, how are multi-state operators (MSOs) adapting...

Via Benzinga

Topics Cannabis

420 with CNW — Spotlight PA Legal Victory Opens Door to Cannabis Research

February 06, 2024

Via CannabisNewsWire

Topics Cannabis

What Gives? The 7 Largest US Cannabis Stocks Are Up 51% YTD ↗

February 03, 2024

The 7 stocks in our American Cannabis MSO Stocks Index jumped 51.3%, on average, YTD. The $64,000 question is why.

Via Talk Markets

Topics Cannabis

420 with CNW — DOJ Says Federal Government Will Ask Court to Throw Out Case Challenging Prohibition

January 31, 2024

Via CannabisNewsWire

Topics Cannabis Lawsuit

Cannabis MSO Stocks Surge: Up 10% Last Week; Up 35% MTD ↗

January 30, 2024

The cannabis MSO stocks have jumped a full 35%, on average, from the tax-loss sell-off that occurred in the latter part of December and the bounce continued last week advancing 10.3%.

Via Talk Markets

Topics Cannabis

Cannabis Chart Of The Week: Who's Growing In Florida, And Has The State Gotten Ahead Of Itself? ↗

January 30, 2024

Florida is often considered one of the most critical states in terms of growing legal cannabis sales. The State is estimated to have approximately $2.6B in 2023 legal sales, representing a per capita...

Via Benzinga

Topics Cannabis

420 with CNW — CDC Study Shows Major Drop in Teen Cannabis Use in Washington’s Largest County Post-Legalization

January 29, 2024

Via CannabisNewsWire

Topics Cannabis

Here's Where To Buy Legal Weed: Cannabis Delivery In New York, New Stores In Five More States, Canada ↗

January 26, 2024

New York has seen the launch of several new adult-use cannabis stores, while stores are opening in California, Connecticut, Illinois, Massachusetts and Pennsylvania, as well as in Canada.

Via Benzinga

Topics Cannabis

DOJ To Federal Court: Don't Disrupt DEA's Rescheduling Process, Drop Cannabis Industry Lawsuit — Legal Tug-Of-War Continues ↗

January 24, 2024

The DOJ's emphasis on the ongoing DEA rescheduling process suggests a potential willingness to reconsider cannabis's classification.

Via Benzinga

Topics Cannabis Lawsuit

DOJ Seeks Dismissal Of Cannabis Industry Lawsuit Challenging Federal Marijuana Prohibition ↗

January 23, 2024

Via Benzinga

Topics Cannabis Lawsuit

Another Push To Legalize Recreational Cannabis In West Virginia Amid Fentanyl Crisis ↗

January 19, 2024

Via Benzinga

Topics Cannabis

420 with CNW — Data Shows Recreational Cannabis Sales Exhibited Mixed Results for Growth in 2023

January 19, 2024

Via CannabisNewsWire

Topics Cannabis

Here's What Made December Stand Out: These Two States Raked In Hundreds Of Thousands In Cannabis Sales ↗

January 17, 2024

Maryland residents spent a record $96.5m on cannabis products in December, according to data from the Maryland Cannabis Administration (MCA). Of that total, $61.5m came from recreational cannabis...

Via Benzinga

Topics Cannabis

Cannabis Stocks And ETFs Trading Higher As Government Recommendations Ignite Hope For Industry ↗

January 16, 2024

Cannabis stocks and ETFs opened higher on Tuesday following the release of documents related to the Department of Health and Human Service's (HHS) review of cannabis. Investors are optimistic about...

Via Benzinga

Topics Cannabis ETFs

New York Kicks Off 2024 With New Legal Weed Shops, Other Stores Open In OH, PA And FLA ↗

January 16, 2024

New York is starting off 2024 with the opening of several cannabis shops, demonstrating the growth and diversification of the state's industry. The Flowery on Staten Island is set to open on 17 January...

Via Benzinga

Topics Cannabis

Largest American Cannabis Stocks Up 16.5% MTD ↗

January 13, 2024

As we expected, the 7 stocks in our American Cannabis MSO Stocks Index have all rebounded from the tax-loss sell-off in late December.

Via Talk Markets

Topics Cannabis

The Pot Piñata: Investors Wanna Know What's Inside ↗

January 12, 2024

By Todd Harrison via Cannabis Confidential (Jan 11) Daily Recap

Via Benzinga

Topics Cannabis

Triple Play: Tracking Booming Markets In Connecticut, Maryland And Maine For Investment Insights ↗

January 11, 2024

Connecticut's Record Sales In December Connecticut experienced a record-breaking December in 2023, with combined sales of adult-use cannabis and medical marijuana surpassing $27.5 million.

Via Benzinga

Topics Cannabis

< Previous 1 2 3 4 5 6 7 8 9

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.